EDWARDS LIFESCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti,

EDWARDS LIFESCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Edwards Lifesciences Corp. - EW

ID: 298594

(firmenpresse) - NEW ORLEANS, LA -- (Marketwired) -- 09/19/13 -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 18, 2013 to file lead plaintiff applications in a securities class action lawsuit against Edwards Lifesciences Corp. (NYSE: EW), if they purchased the Company's securities during the period between April 25, 2012 and April 23, 2013, inclusive (the "Class Period"). This action is pending in the United States District Court for the Central District of California.

What You May Do

If you purchased shares of Edwards Lifesciences and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, call toll-free at 1-877-515-1850, or email KSF Managing Partner Lewis Kahn () or KSF Partner Melinda Nicholson (). If you wish to serve as a lead plaintiff in this class action, you must petition the Court by .

About the Lawsuit

Edwards Lifesciences and certain of its executives are charged with issuing a series of materially false and misleading statements during the Class Period, violating federal securities laws.

These false statements and omissions included, in part, that: (i) adoption of the Company's Edwards SAPIEN transcatheter aortic heart valve, including the related transfemoral and transapical delivery methods, was weaker than the Company claimed, due to concerns among physicians over the risks and complexity of the procedure for implanting the valve; (ii) Edwards Lifesciences' outlook for sales and earnings per share was significantly weaker than the optimistic guidance defendants offered to investors; and (iii) as a result, defendants lacked a reasonable basis for the statements made concerning the Company's operations, forecasts and outlook.

About Kahn Swick & Foti, LLC

To learn more about KSF, whose partners include the Former Louisiana Attorney General, Charles C. Foti, Jr., and other lawyers with significant experience litigating complex securities class actions nationwide on behalf of both institutional and individual shareholders, you may visit .







Contact:

Kahn Swick & Foti, LLC
Lewis Kahn
Managing Partner

Melinda Nicholson
Partner

1-877-515-1850
206 Covington St.
Madisonville, LA 70447


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  KOHL'S 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Securities Class Action Lawsuit Against Kohl's Corp. - KSS GAR Limited Announces Full Revocation of Cease Trade Order
Bereitgestellt von Benutzer: Marketwired
Datum: 20.09.2013 - 02:00 Uhr
Sprache: Deutsch
News-ID 298594
Anzahl Zeichen: 0

contact information:
Town:

NEW ORLEANS, LA



Kategorie:

Legal



Diese Pressemitteilung wurde bisher 289 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"EDWARDS LIFESCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Edwards Lifesciences Corp. - EW"
steht unter der journalistisch-redaktionellen Verantwortung von

Kahn Swick & Foti, LLC (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Kahn Swick & Foti, LLC



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z